CD8A and central nervous system cancer: To determine the frequency of tumour lysate-reactive CD8+ T cells by the IFN-γ ELISPOT assay, monocytes were prepared from the blood of the five glioma patients, loaded with tumour lysate-pulsed DCs, and then cocultured.